ACXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Acurx Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.14+0.04 (+3.64%)
Close on Oct 19, 2026
- Market cap
- $4.86M
- P/E (TTM)
- –
- Dividend yield
- –
Acurx Pharmaceuticals statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Acurx Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $6.01M | $166.30M |
| Enterprise Value | -$4.65M | $88.19M |
| PB Ratio | 0.74 | 2.03 |
| P/TBV Ratio | 0.74 | 2.29 |
Income (trailing twelve months)
| Measure | Acurx Pharmaceuticals | Industry median |
|---|---|---|
| Operating Income | -$7.67M | -$21.40M |
| Net Income | -$7.51M | -$22.46M |
| EBITDA | -$7.67M | -$16.91M |
| EPS (Diluted) | -$3.11 | -$0.83 |
Returns
| Measure | Acurx Pharmaceuticals | Industry median |
|---|---|---|
| Return on Equity (ROE) | -128.1% | -53.2% |
| Return on Assets (ROA) | -68.3% | -40.9% |
| Return on Capital Employed (ROCE) | -94.1% | -38.1% |
Balance sheet
| Measure | Acurx Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $10.66M | $61.43M |
| Net Cash (Debt) | $10.66M | $15.35M |
| Net Cash Per Share | $2.02 | $0.66 |
| Equity (Book Value) | $8.15M | $49.09M |
| Book Value Per Share | $1.55 | $1.37 |
| Tangible Book Value | $8.15M | $23.52M |
Financial position
| Measure | Acurx Pharmaceuticals | Industry median |
|---|---|---|
| Quick Ratio | 3.76 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Acurx Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$6.18M | -$12.35M |
Efficiency
| Measure | Acurx Pharmaceuticals | Industry median |
|---|---|---|
| Profits Per Employee | -$1.88M | -$703.34K |
| Employee Count | 4 | 74 |
Dividends and yields
| Measure | Acurx Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -124.9% | -23.3% |
Shares
| Measure | Acurx Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 5,269,920 | 58,127,000 |
| Shares Change (YoY) | 179.3% | 10.9% |
| Shares Change (QoQ) | 38.2% | 0.54% |
| Float | 2,697,810 | 49,136,700 |
| Shares Held by Insiders | 48.8% | 11.6% |
| Shares Held by Institutions | 2.36% | 59.4% |
Scores
| Measure | Acurx Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | -11.13 | -0.22 |
Calculated by StockData from Acurx Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.